Concepedia

Emily E. Meserve

EE

14

Publications

712

Citations

12

H-Index

2013

Active since

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Harvard University

Stanford University

Massachusetts General Hospital

Emily E. Meserve is an author at Brigham and Women's Hospital specializing in medicine, pathology, and obstetrics.

Top concepts

Publications per year

2013–2021

14

Publications

14

The value of re-exploration in patients with inadvertently morcellated uterine sarcoma

Titilope Oduyebo, Alejandro Rauh-Hain, Emily E. Meserve et al. · Gynecologic Oncology · 2013 · 142 citations

, , +8

Evidence for a Dualistic Model of High-grade Serous Carcinoma

Brooke E. Howitt, Suchanan Hanamornroongruang, Douglas I. Lin et al. · The American Journal of Surgical Pathology · 2015 · 111 citations

, , +22

Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations

James Conner, Emily E. Meserve, Ellen S. Pizer et al. · Gynecologic Oncology · 2013 · 86 citations · Full text

, , +10

Placental Pathology in Neonatal Stroke: A Retrospective Case-Control Study

Miya E. Bernson‐Leung, Theonia K. Boyd, Emily E. Meserve et al. · The Journal of Pediatrics · 2018 · 74 citations

, , +6

Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC)

Helena Møgelbjerg Ditzel, Kyle C. Strickland, Emily E. Meserve et al. · International Journal of Gynecological Pathology · 2018 · 48 citations

, , +16

Rows per page

1–5 of 14